Ubs Group Ag Bionomics Limited Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Bionomics Limited stock. As of the latest transaction made, Ubs Group Ag holds 9,933 shares of BNOX stock, worth $6,655. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,933

Previous 329 2919.15%

Holding current value

$6,655

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.89 - $1.38 $8,547 - $13,253	9,604 Added 2919.15%	9,933 $10,000
Q4 2023 Feb 09, 2024	SELL	$1.13 - $4.46 $2,431 - $9,597	-2,152 Reduced 86.74%	329 $0
Q3 2023 Nov 09, 2023	BUY	$0.95 - $3.37 $2,356 - $8,360	2,481 New	2,481 $6,000
Q4 2022 Feb 08, 2023	BUY	$4.65 - $9.35 $3,464 - $6,965	745 Added 591.27%	871 $4,000
Q3 2022 Nov 10, 2022	BUY	$6.32 - $9.12 $442 - $638	70 Added 125.0%	126 $1,000

Q1 2022 May 16, 2022	SELL	$8.47 - $12.97 $8,249 - $12,632	-974 Reduced 94.56%	56 $0
Q4 2021 Feb 14, 2022	BUY	$12.35 - $14.73 $12,720 - $15,171	1,030 New	1,030 $13,000

Others Institutions Holding BNOX

# of Institutions

Shares Held

370K

Call Options Held

Put Options Held

View Full List

About BIONOMICS LIMITED

Ticker BNOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,518,620
Market Cap $5.04M
Description
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...

More about BNOX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account